Abstract
Various methods have been employed to reduce hepatitis B infections among patients and staff at high risk. Routine screening tests of all blood donors for hepatitis B surface antigen has reduced post-transfusion hepatitis B. After a control and prevention programme was instituted hepatitis B cross-infection was eliminated from haemodialysis units in Britain. Prophylaxis with specific immunoglobulin reduced attack rates of clinical hepatitis B, after accidental inoculation with infective material, to about 2%. Endemic hepatitis B in hospitals for the mentally subnormal remains a problem.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alter H. J., Holland P. V., Morrow A. G., Purcell R. H., Feinstone S. M., Moritsugu Y. Clinical and serological analysis of transfusion-associated hepatitis. Lancet. 1975 Nov 1;2(7940):838–841. doi: 10.1016/s0140-6736(75)90234-2. [DOI] [PubMed] [Google Scholar]
- Grady G. F., Lee V. A. Hepatitis B immune globulin--prevention of hepatitis from accidental exposure among medical personnel. N Engl J Med. 1975 Nov 20;293(21):1067–1070. doi: 10.1056/NEJM197511202932104. [DOI] [PubMed] [Google Scholar]
- Maycock W d'A Hepatitis in transfusion services. Br Med Bull. 1972 May;28(2):163–168. doi: 10.1093/oxfordjournals.bmb.a070918. [DOI] [PubMed] [Google Scholar]
- Polakoff S., Cossart Y. E., Tillett H. E. Hepatitis in dialysis units in the United Kingdom. Br Med J. 1972 Jul 8;3(5818):94–99. doi: 10.1136/bmj.3.5818.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Polakoff S., Maycock W. Anti-HBAg immunoglobulin after inoculation injuries. Dev Biol Stand. 1975;30:329–334. [PubMed] [Google Scholar]
- Polakoff S. The prevention of hepatitis in haemodialysis units. Postgrad Med J. 1971 Jul;47(549):501–503. doi: 10.1136/pgmj.47.549.501. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Seeff L. B., Wright E. C., Finkelstein J. D., Greenlee H. B., Hamilton J., Leevy C. M., Tamburro C. H., Vlahcevic Z., Zimmon D. S., Zimmerman H. J. Efficacy of hepatitis B immune serum globulin after accidental exposure. Preliminary report of the Veterans Administration Cooperative Study. Lancet. 1975 Nov 15;2(7942):939–941. doi: 10.1016/s0140-6736(75)90357-8. [DOI] [PubMed] [Google Scholar]
- Surgenor D. M., Chalmers T. C., Conrad M. E., Friedewald W. T., Grady G. F., Hamilton M., Mosley J. W., Prince A. M., Stengle J. M. Clinical trials of hepatitis B immune globulin. Development of policies and materials for the 1972-1975 studies sponsored by the National Heart and Lung Institute. N Engl J Med. 1975 Nov 20;293(21):1060–1062. doi: 10.1056/NEJM197511202932102. [DOI] [PubMed] [Google Scholar]
- Sutnick A. I., London W. T., Gerstley B. J., Cronlund M. M., Blumberg B. S. Anicteric hepatitis associated with Australia antigen. Occurrence in patients with Down's syndrome. JAMA. 1968 Sep 2;205(10):670–674. [PubMed] [Google Scholar]
- Szmuness W., Prince A. M., Goodman M., Ehrich C., Pick R., Ansari M. Hepatitis B immune serum globulin in prevention of nonparenterally transmitted hepatitis B. N Engl J Med. 1974 Mar 28;290(13):701–706. doi: 10.1056/NEJM197403282901302. [DOI] [PubMed] [Google Scholar]
- Szmuness W., Prince A. M., Grady G. F., Mann M. K., Levine R. W., Friedman E. A., Jacobs M. J., Josephson A., Ribot S., Shapiro F. L. Hepatitis B infection. A point-prevalence study in 15 US hemodialysis centers. JAMA. 1974 Feb 25;227(8):901–906. doi: 10.1001/jama.227.8.901. [DOI] [PubMed] [Google Scholar]